Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays

International Journal of Gynecological Pathology

Volumn 26, Issue 2, 2007, Pages 188-193

  Fons, Guus ^a   Burger, Matthe P ^b   Ten Kate, Fiebo J ^a   Van Der Velden, Jacobus ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Immunohistochemistry; Prognosis; Tissue array analysis; Vulvar neoplasms

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CALCULATION; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR VOLUME; UNIVARIATE ANALYSIS; VALIDATION PROCESS; VULVA CANCER; VULVECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CASPASE 3; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 34147099663     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000228140.94339.db     Document Type: Article

References (18)

1. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 2000;89:116-22.
2. Preti M, Ronco G, Ghiringhello B, et al. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer 2000;88:1869-76.
3. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current international federation of gynecology and obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a gynecologic oncology group study). Am J Obstet Gynecol 1991;164:997-1003.
4. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
5. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
6. Gulmann C, Butler D, Kay E, et al. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 2003;42:70-6.
7. Nocito A, Bubendorf L, Maria TE, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-57.
8. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-51.
9. Adams EJ, Green JA, Clark AH, et al. Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 1999;52:75-7.
10. Chen B, van den Brekel MW, Buschers W, et al. Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 2003;25:922-30.
11. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15:725-31.
12. Koomagi R, Volm M. Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res 2000;20:493-6.
13. Hsia JY, Chen CY, Chen JT, et al. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 2003;29:44-8.
14. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908-16.
15. Ferrandina G, Ranelletti FO, Salutari V, et al. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions. Gynecol Oncol 2004;92:537-44.
16. Chang BW, Kim DH, Kowalski DP, et al. Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res 2004;10:1678-84.
17. Itoh S, Matsui K, Furuta I, et al. Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol 2003;39:829-35.
18. Lim SC, Park SY, Do NY. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma. Oncol Rep 2003;10:1073-9.